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Abstract

Results

Discussion

Unintended pregnancy is a global issue that can result from contraceptive
failure or from a lack of contraceptive use. A literature search was
conducted to explore novel methods of male contraceptives being
developed for improved pregnancy prevention. Seven articles were
selected, reporting on either oral contraceptive pills, transdermal gel,
injectable hormonal, or intravas polymer injection. The most common
adverse events reported across all studies include changes in libido,
mood, weight gain, acne, and headache. After reaching hormone and
sperm concentration levels sufficient for pregnancy prevention, authors
reported complete reversibility of contraceptive effects. Four studies
described changes in various safety laboratory tests, including cholesterol
and hemoglobin. Though more research is needed, novel male
contraceptives may be effective in preventing unintended pregnancy.

Of the seven articles included, six studied novel male
hormonal methods and one studied a nonhormonal method
of intravas deferens polymer injection. All studies measured
efficacy, either by serum gonadotropin suppression, sperm
concentration, or pregnancy rate. All evaluated the safety of
each given method, and some reported on the reversibility of
its effects.

• When reported, efficacy of novel male contraceptives was found to be
higher than condoms (~18% failure rate).
• While the data indicates that these methods will provide
effective contraception, long term studies are necessary to
measure the incidence of pregnancy and azoospermia after
a complete cycle of spermatogenesis- approximately 72
days.
• Common adverse effects of these methods include acne, weight gain,
and mood changes. No significant adverse effects were reported.
• These side effects are comparable to those seen with
current use of female hormonal contraceptives but may be
viewed as unfavorable by some men.
• Common changes in safety laboratory tests included changes in lipid
panels and complete blood counts.
• Providers will need to be aware of these effects to
determine which method is appropriate for a given patient.
• When reported, participants experienced full recovery of either serum
hormones or sperm concentrations to baseline after discontinuing use.
These methods may leave long term fertility intact, which would
appeal to patients compared to poorly reversible vasectomy.
• Condoms remain the only method that protect against sexually
transmitted infections.

Introduction
Nearly half (45%) of all pregnancies in the U.S. are estimated to be
unintended.1 Unintended pregnancies are associated with increased risk
2,3
of negative outcomes for mothers and babies. Currently, contraception
is heavily reliant on female methods, as modern male methods only
include condoms and vasectomy. Novel male methods being developed
include both nonhormonal and hormonal methods. The availability of
these new methods would broaden contraceptive choice and allow men
to take a more active role in family planning. This review analyzes
evidence to evaluate the safety, efficacy, and reversibility of novel male
contraceptives compared to current methods in adult patients seeking to
prevent pregnancy.

Methods

A literature search was completed using PubMed, Academic Search
Ultimate, and Google Scholar. Seven articles were selected based on
relevance to the research question and fulfillment of eligibility criteria.
§ Inclusion Criteria
§ Adult participants
§ Clinical trial or randomized controlled trial of novel
contraceptive method
§ Published between 2016 and 2022
§ Full text
§ In English (studies not limited to U.S.)

Table 1. Study and Method Characteristics

Study

Type

Contraceptive Method

Contraceptive
Administration

14

Double Blind RCT

Daily

25

Double Blind RCT

36

Non-blinded RCT

47

Double Blind RCT

58

Combination T and
progestin gel
Modified testosterone oral
contraceptive pill
Combination T and
progestin gel
Dimethandrolone oral
contraceptive pill
Intravas polymer Injection

Phase III clinical
trial
Phase II clinical Gluteal progesterone and
trial
testosterone injection
Double Blind RCT
Dimethandrolone oral
contraceptive pill

69
710

Daily
Daily
Daily
Once
Every 3 months
Daily

Conclusion

Note: RCT= randomized controlled trial; T= testosterone
Table 2. Study Outcomes

Study

Efficacy

1

G.T. suppression
(p<0.001)
G.T. suppression
(p<0.029)
G.T. suppression, ↓
sperm conc. (p<0.001)

2
3

4
5
6
7

Safety

Reversibility

rash, sunburn at gel site Fully reversible
↑ LDL-C, ↓ HDL-C,
weight gain, acne, HA
↓ hemoglobin,
hematocrit, insulin
sensitivity, △mood
↑ LDL-C, ↓ HDL-C

N.S.
Fully reversible

G.T. not significantly
N.S.
suppressed (p>0.05)
100% azoospermia by Temporary scrotal and
N.S.
6m; 0% pregnancy rate
inguinal pain
95.9% azoospermia by Acne, injection site pain, Fully reversible
6m; 1.57% preg. rate increased libido, △mood
G.T. suppression
↑ weight, ↓ HDL-C, HA, Fully reversible
(p<0.001)
decreased libido

Note: G.T.= gonadotropins; LDL-C= low-density lipoprotein cholesterol; HDLC= high-density lipoprotein cholesterol; HA= headache; N.S.= not studied

The evidence from this paper demonstrates that both hormonal and
nonhormonal methods of novel male contraception are well tolerated by
most men, have acceptable safety profiles, and can be effective for
pregnancy prevention. While they demonstrated overall safety in short
term trials, long term studies are needed to demonstrate lasting safety
and reversibility of each respective method for males seeking to utilize
them. Longer studies that evaluate pregnancy rates will provide more
evidence for or against use of novel contraceptives for pregnancy
prevention compared to methods currently available.
References:
1. Unintended Pregnancy. cdc.gov. Updated June 28, 2021. Accessed January 23, 2022. https://www.cdc.gov/reproductivehealth/contraception/unintendedpregnancy/index.htm

2. Finer LB, Zolna MR. Declines in unintended pregnancy in the United States. The New England Journal of Medicine. 2016;374, 843-852. doi: 10.1056/NEJMsa1506575
3. Everett BG, McCabe KF, Hughes TL. Unintended pregnancy, depression, and hazardous drinking in a community-based sample of sexual minority women. Journal of Women’s Health. 2016;25(9), 904911. doi: 10.1089/jwh.2015.5290
4. Anawalt BD, Roth MY, Ceponis J et al. Combined nestorone-testosterone gel suppresses serum gonadotropins to concentrations associated with effective hormonal contraception in men. Andrology.
2019;7, 878-887. doi: 10.1111/andr.12603
5. Yuen F, Thirumalai A, Pham C et al. Daily Oral Administration of the Novel Androgen 11β-MNTDC Markedly Suppresses Serum Gonadotropins in Healthy Men. J Clin Endocrinol Metab. 2020;105(3),
e835-e847. doi: 10.1210/clinem/dgaa032
6. Zitzmann M, Rohayem J, Raidt J et al. Impact of various progestins with or without transdermal testosterone on gonadotropin levels for non-invasive hormonal male contraception: A randomized
clinical trial. Andrology. 2017;5(3), 516-526. doi:10.1111/andr.12328
7. Ayoub R, Page ST, Swerdloff RS, et al. Comparison of the single dose pharmacokinetics, pharmacodynamics, and safety of two novel oral formulations of dimethandrolone undecanoate (DMAU): a
potential oral, male contraceptive. Andrology. 2017;5, 278-285. doi: 10.1111/andr.12303
8. Sharma RS, Mathur AK, Singh R, et al. Safety & efficacy of an intravasal, one-time injectable & non-hormonal male contraceptive (RISUG): A clinical experience. Indian J Med Res. 2019;150(1), 81-86.
doi: 10.4103/ijmr.IJMR_635_18
9. Behre HM, Zitzmann M, Anderson RA, et al. Efficacy and safety of an injectable combination hormonal contraceptive for men. The Journal of Clinical Endocrinology and Metabolism. 2016;101(12),
4779-4788. doi:10.1210/jc.2016-2141
10. Thirumalai A, Ceponis J, Amory JK et al. Effects of 28 days of oral dimethandrolone undecanoate in healthy men: a prototype male pill. The Journal of Clinical Endocrinology & Metabolism.
2019;104(2), 423-432. doi: https://doi.org/10.1210/jc.2018-01452
Zitzmann M, Rohayem J, Raidt J et al. Impact of various

